hVIVO plc
Opening hours
- Monday
- 09:00 – 18:00
- Tuesday
- 09:00 – 18:00
- Wednesday
- 09:00 – 18:00
- Thursday
- 09:00 – 18:00
- Friday
- 09:00 – 18:00
- Saturday
- Closed
- Sunday
- Closed
Events
8 events
Event
The future of cardiometabolic trials: From obesity to outcomes that matter
Sat, 15 Aug
On-demand online webinar exploring how early cardiometabolic development programmes can generate meaningful pharmacodynamic evidence alongside safety and pharmacokinetics. The discussion covers endpoints beyond weight loss, cardiometabolic comorbidities, earlier involvement of patient populations, and advanced metabolic, biomarker, and functional assessments. Designed for professionals involved in early cardiometabolic drug development, including clinical development, translational medicine, clinical pharmacology, biomarker, clinical science, endpoint strategy, pre-clinical, medical, R&D, and portfolio teams.
ViewEvent
Accelerate Your hMPV Programme with hVIVO's Challenge Model
Sat, 15 Aug
On-demand webinar for those advancing Human Metapneumovirus research. Discover how the world's only contemporary-strain hMPV human challenge model can support development goals, with high infection and symptomatic disease rates, robust virological outcomes, and suitability for vaccine and antiviral trials.
ViewEvent
Smarter Molecular Strategies for Infectious Disease Trials: Turning Complex Data into Clinical Advantage
Sat, 15 Aug
On-demand webinar exploring how next-generation sequencing, droplet digital PCR and 3' RNA-seq can support pathogen detection, resistance monitoring and host-response biomarker discovery. The session covers integrated molecular workflows, pathogen quantification, resistance surveillance, operational considerations for early-phase clinical programmes, challenge studies and antiviral development timelines.
ViewEvent
EASD 2026
Mon, 28 Sept
The EASD 2026 Annual Meeting is one of the world’s leading forums for diabetes research and clinical innovation, bringing together scientists, clinicians, healthcare professionals, and industry partners to advance understanding and treatment of diabetes. The meeting highlights cutting-edge research, emerging therapies, technological breakthroughs, and real-world clinical insights.
ViewEvent
AAPS 2026 PHarmSCi 360
Sun, 25 Oct
A leading global meeting for pharmaceutical scientists, bringing together researchers, formulation experts, regulatory specialists, and industry innovators to advance the science and technology behind drug development. The conference highlights cutting-edge research, emerging modalities, advances in biopharmaceutical manufacturing, and practical insights across the full spectrum of pharmaceutical science.
ViewEvent
BIO-Europe 2026
Mon, 9 Nov
hVIVO will be attending BIO-Europe, the leading partnering event for the global biotechnology and biopharma industry. The event brings together thousands of senior decision-makers from pharma, biotech, and investment communities for strategic connections, partnership opportunities, one-to-one partnering meetings, licensing, investment, and collaboration. hVIVO will discuss its early-phase clinical, human challenge, and consultancy capabilities.
ViewEvent
19th EBF Open Symposium
Tue, 17 Nov
The 19th EBF Open Symposium brings together leading scientists, bioanalytical experts, regulators, and industry partners to discuss the latest developments shaping quantitative bioanalysis in drug development. The symposium features scientific sessions, regulatory perspectives, emerging technologies, and collaborative discussions focused on advancing high-quality, reliable bioanalytical science.
ViewEvent
Dutch Life Sciences Conference 2026
Thu, 26 Nov
hVIVO will be attending the Dutch Life Sciences Conference, bringing together leaders across biotech, pharma, academia and investment. The conference focuses on collaboration, partnership-building, business growth, emerging trends, cutting-edge technologies, investor engagement and scaling innovation. hVIVO's team will be on-site to discuss early-phase clinical, infectious disease and consultancy expertise.
ViewAbout
Hours and details
The future of cardiometabolic trials: From obesity to outcomes that matter
- Medical lab
- Health and medicine
- Business and professional services
